Creating guidelines for prostate cancer care using expert opinions
Official title: Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study
Run by M.D. Anderson Cancer Center · NCT05054413 · Data updated 2026-11-12
This study is trying to create clear guidelines for prostate cancer care by gathering opinions from experts to help doctors provide better and more consistent treatment for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | April 15, 2021 |
| Main results expected | August 1, 2030 |
| Study ends | August 1, 2030 |
| Registry record updated | May 26, 2026 |
| Trial ID | NCT05054413 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are board-certified medical providers actively treating prostate cancer patients.
✕Probably not a fit
Patients who are not medical providers or those who do not treat prostate cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to establish consensus guidelines for key clinical elements in prostate cancer care through a remote Delphi method. A panel of certified experts in relevant fields will participate in multiple rounds of questionnaires to identify essential data elements for standardized reporting in electronic health records. The goal is to enhance the management of prostate cancer patients from diagnosis through survivorship by ensuring consistency in the information recorded. The study emphasizes the importance of expert input in developing these guidelines to improve patient care.
Why it matters
Potential benefit: If successful, this study could lead to improved standardization in prostate cancer care, enhancing patient management and outcomes.
How similar studies have gone: While similar consensus-building approaches have been utilized in other areas of cancer care, this specific application using the Delphi method for prostate cancer is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 21 and above * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology * Maintenance of an active practice that includes prostate cancer patients * English speaking Exclusion Criteria: * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer * Prisoners, children, and adults unable to consent to participation will also be excluded * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Amy C Moreno — M.D. Anderson Cancer Center
- Study coordinator: Amy C Moreno
- Email: akmoreno@mdanderson.org
- Phone: 713-745-4590
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Video education to boost knowledge and interest in cancer clinical trials
Adults in the Detroit area will watch a short educational video to see if it increases their knowledge about and interest in cancer clinical trials.
-
Using alteplase to improve fluid drainage and breathlessness in patients with malignant pleural effusion
This study tests if the medication alteplase can help people with fluid buildup in the lungs feel better and breathe easier when regular drainage isn’t enough.
-
Using weighted blankets to reduce anxiety in cancer patients during infusions
This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.
-
Letermovir to prevent cytomegalovirus after pediatric stem cell transplant
This study will try giving letermovir to CMV-positive children and adolescents receiving allogeneic stem cell transplants to see if it lowers CMV infections after transplant compared with the expected rate without prophylaxis.
-
Collecting blood and tissue samples for HIV/AIDS-related cancer research
This study is collecting blood and tissue samples from people living with HIV and related cancers to help researchers learn more about how HIV affects cancer development.
-
Collecting blood samples to evaluate tests for early cancer detection
This study is collecting blood and tissue samples from people with and without cancer to see if new tests can help detect cancer earlier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.